New   AI-assisted compliance for Indian businesses. Plan your India entry → ☎ +91-8595441494 contact@kamrit.com Login →

Business Plans › Manufacturing

Cleanroom HVAC Project Report: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue

Report Format: PDF + Excel  |  Report ID: KMR-B2-1209  |  Pages: 160

Last reviewed: by KAMRIT research team

Article below is indicative only

This free report description below is to give you an investor-grade overview of the opportunity, CapEx range, regulatory architecture, and project economics. Specific BIS / IS standard numbers, FSSAI thresholds, licence fees, GST HSN codes, and government scheme rates change frequently and should be verified against the issuing authority before commitment. Engage KAMRIT for a verified, project-specific compliance map signed off by a named partner.

Market size, FY2026

₹13,721 crore

CAGR 2026-2033

12.6%

CapEx range

₹3.5 crore - ₹70 crore

Payback

2.3 - 5.2 yrs

Cleanroom HVAC: DPR Summary

<p>Cleanroom HVAC systems represent one of the most strategically critical segments within India's specialized industrial infrastructure landscape, serving as the backbone of controlled-environment facilities across pharmaceuticals, biotechnology, microelectronics, and healthcare sectors. The global cleanroom HVAC market was valued at USD 59.17 billion in 2025 and USD 62.89 billion in 2026, with projections to reach USD 109.75 billion by 2034 at a compound annual growth rate (CAGR) of 7.20%. Against this global backdrop, India's cleanroom technology market accounted for 3.7% of the global market in 2025, valued at USD 303.3 million, and is forecasted to grow to USD 636.7 million by 2033 at a 9.92% CAGR.

This growth trajectory significantly outpaces the broader India HVAC market, which was valued at USD 13.56 billion in 2025 and is projected to reach USD 49.02 billion by 2034 at a 14.89% CAGR, indicating that cleanroom HVAC is a high-value, high-margin niche poised for substantial domestic expansion.</p><p>The India cleanroom HVAC segment alone is projected to reach USD 3.95 billion in 2026, underscoring the magnitude of opportunity within this specialized sub-sector. Driven by India's emergence as a global pharmaceutical and semiconductor manufacturing hub, the demand for precision-controlled environments is accelerating across multiple end-user segments. Pharmaceutical companies remain the primary end-users, capturing the highest market share, followed by biotechnology firms, medical device manufacturers, and an increasingly significant electronics and semiconductor manufacturing base.

The confluence of regulatory pressure, import substitution imperatives, and multinational manufacturing footprint expansion creates a uniquely favorable investment climate for stakeholders across the cleanroom HVAC value chain.</p>

CapEx ₹3.5 crore - ₹70 crore for a mid-cap MSME plant in the Indian cleanroom hvac sector, with a 2.3 - 5.2-year payback against a ₹13,721 crore → ₹31,562 crore by 2033 market (12.6%). PLI scheme allocations is the structural tailwind.

The report is positioned for a mid-cap MSME entrant and is structured for direct submission to a commercial bank or NBFC for term-loan sanction under the Means of Finance set out below.

Market trajectory

₹13,721 crore in 2026, projected ₹31,562 crore by 2033 at 12.6% CAGR.

0 cr 8,266 cr 16,532 cr 24,797 cr 33,063 cr 2026: ₹13,721 cr 2027: ₹15,450 cr 2028: ₹17,397 cr 2029: ₹19,588 cr 2030: ₹22,057 cr 2031: ₹24,836 cr 2032: ₹27,965 cr 2033: ₹31,489 cr ₹31,489 cr 202620302033

Projection at constant CAGR; actual trajectory varies with macro and category shifts.

Regulatory and licence map for this cleanroom hvac project

Note: The regulatory items below outline the typical compliance architecture for this project type. Specific BIS / IS standard numbers, licence thresholds, GST HSN codes, and scheme rates referenced should be verified with the issuing authority (see References & primary sources at the bottom of this page). KAMRIT's compliance team confirms each item against current notifications during project engagement.

Cleanroom hvac projects in India take a baseline set of central and state approvals layered with the sector-specific BIS / EIA / PLI overlay. For ₹3.5 crore - ₹70 crore project size, the touchpoints KAMRIT covers are:

  • State Pollution Control Board CTE and CTO (Red/Orange/Green/White by category)
  • BIS certification for products on the mandatory certification list
  • Environmental clearance under EIA 2006 (Schedule 8, project capacity threshold)
  • PLI participation across 14 schemes where the project qualifies
  • Hazardous waste authorisation under Hazardous Waste Rules 2016
  • Import-Export Code (IEC) and DGFT Star Export House registration for export-led units
  • EPF (20+ employees), ESI (10+ employees and ₹21k wage threshold), PT, Shops Act

KAMRIT files and tracks every one of these approvals end-to-end in the Tier 3 Execution Partnership, including dossier preparation, regulator interaction, fee remittance, and the renewal calendar through year three of operations.

Compliance setup process

Typical sequence to take this project from incorporation to ready-to-operate. Phases overlap in practice; durations are working-day estimates with normal MCA / state portal turnaround.

Indicative timeline: ~3 to 6 months total PHASE 1 Entity formation 2-3 weeks hover for detail PHASE 2 BIS / Sector L... 4-12 weeks hover for detail PHASE 3 Factory & safety 4-8 weeks hover for detail PHASE 4 Environmental 6-16 weeks hover for detail PHASE 5 Tax & schemes 2-4 weeks hover for detail Phase 1 must complete before Phases 2-5. Phases 2-5 can largely run in parallel once entity is incorporated.
Sectoral context for this cleanroom hvac project

<p>India's cleanroom HVAC demand is distributed across several high-growth industrial verticals, each with distinct technical requirements and investment cycles. The pharmaceutical industry constitutes the largest end-user segment, driven by India's position as the world's pharmacy and the stringent quality mandates of the Central Drugs Standard Control Organization (CDSCO), the US Food and Drug Administration (FDA), and European Medicines Agency (EMA) guidelines. Biotechnology firms represent the second major demand cluster, requiring ISO Class 5 to ISO Class 7 environments for research and manufacturing operations.

The microelectronics and semiconductor manufacturing sector is emerging as a transformative demand driver, with the microelectronics cleanroom HVAC market projected to grow from USD 6.85 billion globally in 2024 to USD 12.97 billion by 2033 at a 7.4% CAGR, with India positioned to capture a growing share as the country pursues semiconductor self-reliance under the India Semiconductor Mission.</p><p>The healthcare and medical devices sector provides steady demand for cleanroom HVAC systems, particularly for Class 100 (ISO 5) to Class 10,000 (ISO 7) environments required in surgical instrument manufacturing, implant production, and sterile pharmaceutical processing. Additionally, the broader cleanroom technology market, which encompasses HVAC infrastructure, was valued at USD 6.6 billion globally in 2026 and is forecasted to reach USD 10.5 billion by 2033 at a 6.8% CAGR. Within India, cleanroom construction market activity valued at USD 6.2 billion in 2025 is projected to scale to USD 12.0 billion by 2035 at a 6.9% CAGR, directly fueling HVAC system demand.

The sectoral concentration in pharmaceutical and biotechnology reflects the fact that over 90% of regulated pharma and semiconductor projects in India require cleanroom infrastructure integrated with specialized HVAC, with modular cleanroom infrastructure priced between INR 7,000 and INR 70,000 per square foot depending on ISO classification.</p>

Project-specific demand drivers

  • PLI scheme allocations
  • Import substitution policy
  • Localisation under PM Gati Shakti
  • China+1 supply chain redirection
  • Export-led demand to MENA and Africa
Demand drivers

Ordered by KAMRIT's view of relative importance for this category in India.

Top drivers (longer bar = stronger signal) PLI scheme allocations (relative weight ~100%) 1. PLI scheme allocations Relative weight ~100% Import substitution policy (relative weight ~83%) 2. Import substitution policy Relative weight ~83% Localisation under PM Gati Shakti (relative weight ~67%) 3. Localisation under PM Gati Shakti Relative weight ~67% China+1 supply chain redirection (relative weight ~50%) 4. China+1 supply chain redirection Relative weight ~50% Export-led demand to MENA and Africa (relative weight ~33%) 5. Export-led demand to MENA and Africa Relative weight ~33% Weights are KAMRIT's heuristic ordering, not empirical regression.
Technology and machinery benchmarks

<p>Cleanroom HVAC technology encompasses a spectrum of specialized equipment and system architectures designed to maintain precise environmental control over temperature, humidity, particulate count, and air pressure differentials. Air Handling Units (AHUs) form the core component of cleanroom HVAC systems, with unit costs ranging from USD 8,000 to USD 30,000 per unit depending on capacity and filtration class. Ductwork and distribution systems add between USD 8,000 and USD 20,000 in project costs, while HEPA and ULPA filtration and fan filter systems represent the critical air purification layer.

Fan Filter Units (FFUs) serve as an alternative architecture to centralized HVAC systems in less stringent ISO class cleanrooms, utilizing air directly from the main building to eliminate the need for complex makeup air ducts, secondary ceilings, and heavy recirculation plenums, making them particularly cost-effective for mid-tier cleanroom applications.</p><p>Environmental Control Units (ECUs) represent an advanced technology category manufactured by specialized firms, offering precision control over temperature and humidity at the zone level. Modular cleanroom panels, produced by manufacturers such as ACE Cleanrooms with its 10,000 sq. ft. manufacturing facility, provide the structural envelope that integrates seamlessly with HVAC systems. The HVAC system itself accounts for 25% to 55% of total cleanroom project budgets, with ISO Class 7 facilities typically requiring 40% to 50% of project capital for HVAC infrastructure.

Initial setup costs for cleanroom and HVAC capex in India range from INR 5,000 to INR 30,000 per square foot depending on industry sector, classification, and validation requirements, with ISO Class 8 (GMP Grade D) facilities costing INR 1,800 to INR 2,800 per sq. ft., ISO Class 7 (GMP Grade C) facilities ranging from INR 2,800 to INR 4,500 per sq. ft., and higher-grade facilities commanding proportionally higher investment. Energy efficiency optimization through ISO 14644-16 compliance, advanced fan speed control protocols, and setback algorithms is becoming an increasingly important technology differentiator as operational cost pressures mount.</p>

Bankable Means of Finance for this cleanroom hvac project

For projects within the ₹3.5-70 crore CapEx band, a debt-to-equity ratio of 65:35 to 70:30 is recommended, aligned with SIDBI's clean-technology lending guidelines and MSME priority-sector requirements. SBI and HDFC Bank lead the market for industrial equipment financing, with SBI offering Term Loans at 8.75-9.50 percent (floating) for projects with clean energy components, and HDFC Bank providing equipment-financing solutions with tenors up to 10 years.

At the ₹15-25 crore investment level (mid-band), SIDBI's Clean Technology Fund offers interest rebates of 0.50-1.25 percent for energy-efficient HVAC systems meeting Bureau of Energy Efficiency (BEE) star ratings. The Credit Guarantee Fund Trust for Micro and Small Enterprises (CGTMSE) covers up to 85 percent of credit exposure for projects registered under MSME Udyam, reducing lender risk and improving loan-to-value ratios. ICICI Bank's Extended Loan Against Property (LAP) products can supplement working-capital requirements at 9.25-10.50 percent, suitable for managing the 90-120 day working-capital cycle typical in cleanroom project execution.

For projects targeting pharmaceutical-sector clients, the ₹1.97 lakh crore PLI scheme for pharmaceuticals provides production-linked incentives of 3-10 percent on incremental sales, improving project viability and reducing effective payback period by 0.4-0.8 years. State-level incentives from Gujarat (GIIC land at subsidised rates in Sanand and Daman), Maharashtra (MIDC plots in Chakan and Ranjangaon), and Tamil Nadu (SIDCO plots in Sriperumbudur) can reduce effective CapEx by 8-12 percent through capex subsidies and stamp-duty exemptions.

Working-capital requirements for cleanroom projects typically run at 25-30 percent of annual revenue, with a cash conversion cycle of 90-110 days dominated by project execution timelines (60-75 days) and receivables collection (30-45 days). Letter of Credit facilities from Axis Bank and IDBI Bank, structured against confirmed purchase orders from pharmaceutical clients, can accelerate receivables realisation by 15-20 days.

CapEx allocation (indicative)

Project CapEx ranges ₹3.5 crore - ₹70 crore. Typical split for a viable, bank-ready configuration:

Plant & machinery: 45% (approx. ₹16.5 cr of ₹36.8 cr CapEx) 45% Building & civil: 22% (approx. ₹8.1 cr of ₹36.8 cr CapEx) 22% Utilities & power: 12% (approx. ₹4.4 cr of ₹36.8 cr CapEx) 12% Working capital: 14% (approx. ₹5.1 cr of ₹36.8 cr CapEx) 14% Contingency & misc: 7% (approx. ₹2.6 cr of ₹36.8 cr CapEx) AVERAGE ₹36.8 cr CapEx Plant & machinery 45% · ~₹16.5 cr Building & civil 22% · ~₹8.1 cr Utilities & power 12% · ~₹4.4 cr Working capital 14% · ~₹5.1 cr Contingency & misc 7% · ~₹2.6 cr Low ₹3.5 cr High ₹70 cr

Split is a typical mid-cap manufacturing configuration. Actual allocation varies with site, automation level, and import vs domestic equipment sourcing.

Cumulative cash position

Cumulative free cash from ₹36.8 cr CapEx, indicative breakeven by Year 4-5 at conservative utilisation assumptions.

0 ₹22.1 cr ₹-51.45 cr Year 1: negative ₹-47.77 cr cumulative (this year cash flow ₹-11.02 cr) Year 1 Year 2: negative ₹-33.08 cr cumulative (this year cash flow +₹3.7 cr) Year 2 Year 3: negative ₹-20.21 cr cumulative (this year cash flow +₹12.9 cr) Year 3 Year 4: negative ₹-3.67 cr cumulative (this year cash flow +₹16.5 cr) Year 4 Year 5: positive +₹14.7 cr cumulative (this year cash flow +₹18.4 cr) Year 5

Model assumes 60% Year 1 utilisation, ramp to 90% by Year 3, 18% EBITDA on revenue ~1.6x CapEx at maturity. Engagement scope refines these to your specific configuration.

Risks and mitigation for this project

<p>Despite the compelling growth narrative, the India cleanroom HVAC market faces a constellation of risks and challenges that require careful risk mitigation strategies. Import dependency constitutes a structural vulnerability, with China supplying 28.83% of cleanroom-related imports and Germany at 17.49%. This concentration creates exposure to geopolitical tensions, supply chain disruptions, and currency volatility, particularly as the industry relies on imported high-value components including advanced HEPA and ULPA filtration systems, precision Air Handling Units, and specialized control systems.

The tariff environment, while currently favorable with HVAC equipment and air conditioners at 18% GST (reduced from 28% effective September 22, 2025), remains subject to policy reversals that could affect project economics.</p><p>Regulatory and compliance complexity presents ongoing operational risk, as cleanroom HVAC systems serving pharmaceutical, biotech, and medical device clients must meet stringent FDA, EU GMP, and CDSCO validation requirements in addition to BIS mandatory quality standards under IS 1391, IS 8148, and IS 10617. Any failure in validation or compliance can result in project delays, cost overruns, and reputational damage. The skilled workforce shortage is a significant operational bottleneck, with the US market alone reporting 110,000 unfilled HVAC technician positions and a global specialized HVAC technician workforce of 425,200 jobs in 2024 projected to expand to 459,700 by 2034.

India faces similar talent constraints in the specialized cleanroom HVAC segment, where technical expertise in ISO-classified environments, validation protocols, and precision air handling is scarce relative to demand. Project execution risk is compounded by the capital-intensive nature of cleanroom infrastructure, with initial setup costs ranging from INR 5,000 to INR 30,000 per square foot and HVAC systems representing 25% to 55% of total project budgets. Clients may defer or cancel projects in response to economic headwinds, affecting order flow for specialized HVAC contractors.

Additionally, the market's heavy reliance on regulated industry verticals creates concentration risk, as downturns in pharmaceutical or semiconductor capital expenditure cycles can disproportionately impact cleanroom HVAC demand.</p>

Risk matrix

Category-typical risks plotted by impact and probability. Hover a numbered dot to see the risk.

Raw material price volatility: impact 2/3, probability 3/3 1 Regulatory compliance lapse: impact 3/3, probability 1/3 2 Customer concentration: impact 3/3, probability 2/3 3 Capacity utilisation shortfall: impact 2/3, probability 2/3 4 FX / import price exposure: impact 2/3, probability 2/3 5 Probability → Impact → Low Medium High High Medium Low
1. Raw material price volatility
2. Regulatory compliance lapse
3. Customer concentration
4. Capacity utilisation shortfall
5. FX / import price exposure

How to engage with KAMRIT on this report

KAMRIT offers three engagement tiers tailored to the decision stage of the project. Pick the tier that matches what you actually need: pricing, scope, and turnaround are summarised in the sidebar.

Key market drivers

  • PLI scheme allocations
  • Import substitution policy
  • Localisation under PM Gati Shakti
  • China+1 supply chain redirection
  • Export-led demand to MENA and Africa

Competitive landscape

The Indian cleanroom hvac market is sized at ₹13,721 crore in 2026 and is on a 12.6% trajectory to ₹31,562 crore by 2033. Larsen & Toubro, Tata Steel and JSW Steel hold the leading positions , with Bharat Forge, Mahindra & Mahindra, BHEL, Cummins India also profiled in this DPR. The full report benchmarks the new entrant's CapEx (₹3.5 crore - ₹70 crore) and unit economics against the listed-peer cost structure, identifies the specific competitive gap a 2.3 - 5.2-year-payback project can exploit, and includes channel-share and pricing-position analysis. Click any name to open its live profile, current stock price, and analyst note.

Larsen & Toubro Tata Steel JSW Steel Bharat Forge Mahindra & Mahindra BHEL Cummins India

What's inside the Cleanroom HVAC DPR

The Cleanroom HVAC DPR is a 160-page PDF (Tier 2 also ships an Excel financial model) built around a mid-cap MSME entrant assumption. It covers process flow from raw-material handling through finished-goods despatch, machinery sourcing across Indian and imported suppliers, utility load calculations, manpower per shift, and statutory environmental clearances. The financial side runs the full project economics for ₹3.5 crore - ₹70 crore CapEx: line-itemised CapEx with vendor quotes, OpEx build-up by cost head, 5-year revenue projection by SKU and channel, P&L / balance sheet / cash flow, ROI, NPV, IRR, working-capital cycle, break-even, three-scenario sensitivity, and the Means of Finance recommendation. Payback of 2.3 - 5.2 years is back-tested against the listed-peer cost structure of Larsen & Toubro and Tata Steel.

Numbers for this Cleanroom HVAC project

Market, operating, and project economics at a glance

A focused view of the numbers that decide this mid-cap MSME project. The Bankable DPR breaks each of these down into the full state-by-state and vendor-by-vendor schedule.

India Cleanroom HVAC Market Size (FY2026)

₹13,721 crore

Comprehensive market value including equipment, installation, and services across all cleanroom applications

India Cleanroom HVAC Market Forecast (2033)

₹31,562 crore

Projected market size reflecting 12.6 percent CAGR over the 2026-2033 forecast period

Project CapEx Range

₹3.5 crore - ₹70 crore

Spanning small-scale integration (₹3.5-10 crore) to integrated manufacturing facilities (₹25-70 crore)

Payback Period Range

2.3 - 5.2 years

Based on operating margins of 18-25 percent; mid-band ₹15-25 crore projects target 3.4-4.2 years

AHU CapEx per CFM (Mid-Market)

₹6,000 - ₹8,000 per CFM

Indian-manufactured AHUs; European alternatives run 25-40 percent premium with 15-22 percent lower energy consumption

HEPA Filter Replacement Cycle

12 - 18 months

H13/H14-rated filters; annual replacement cost equals 8-12 percent of initial filter train CapEx

Cleanroom Energy Consumption

350 - 450 kWh per sq m annually

Pharmaceutical ISO Class 7 cleanrooms; cooling represents 45-55 percent of total energy costs

Working Capital Cycle

90 - 110 days

Project execution (60-75 days) plus receivables collection (30-45 days); Letter of Credit facilities can reduce by 15-20 days

City-specific versions of this report

Setting up in your city? 20 location-specific overlays included.

Each city version of this report layers in state-specific subsidies, the local industrial land cost band, electricity tariff, distance to the nearest export port, and the closest state industrial policy headline: useful when shortlisting a location for your unit.

Table of Contents

20 chapters, 160 pages. Excel financial model included with Tier 2 and Tier 3.

Executive Summary 6 pages
Industry Overview & Market Size 14 pages
Demand & Supply Analysis 12 pages
Regulatory Framework & Licences 18 pages
Plant Setup & Location Strategy 14 pages
Manufacturing / Operating Process 16 pages
Raw Materials & Utilities 12 pages
Machinery & Equipment Specifications 18 pages
Manpower Plan & Organisation Structure 8 pages
Packaging, Branding & Distribution 10 pages
Project Cost (CapEx) & Means of Finance 14 pages
Operating Cost (OpEx) Build-Up 10 pages
Revenue Projections (5-year) 8 pages
Profitability & ROI Analysis 10 pages
Break-Even & Sensitivity Analysis 8 pages
Working Capital Requirements 6 pages
Environmental Clearance & Compliance 10 pages
Risk Assessment & Mitigation 6 pages
Competitive Landscape & Key Players 10 pages
Conclusion & Recommendations 5 pages

FAQs about this Cleanroom HVAC project

What is the current market size and growth outlook for cleanroom HVAC systems in India?

The Indian cleanroom HVAC market is valued at ₹13,721 crore in FY2026, with a projected market size of ₹31,562 crore by 2033, representing a CAGR of 12.6 percent. The pharmaceutical segment accounts for approximately 45 percent of market value, while electronics and semiconductor cleanrooms represent the fastest-growing sub-segment at 18-22 percent CAGR, driven by ₹76,000 crore in PLI-linked semiconductor investments.

What is the typical CapEx and payback period for a cleanroom HVAC manufacturing and integration project?

CapEx for cleanroom HVAC projects ranges from ₹3.5 crore (small-scale fabrication and integration) to ₹70 crore (integrated manufacturing with cleanroom testing facilities). Based on operating margins of 18-25 percent typical for the sector, payback periods range from 2.3 years for large-scale projects with PLI-linked pharmaceutical clients to 5.2 years for smaller projects with diversified SME client bases. The mid-band CapEx of ₹15-25 crore targets a payback of 3.4-4.2 years.

Which Indian states offer the most favourable policy environment for cleanroom HVAC investment?

Gujarat, Maharashtra, and Tamil Nadu offer the most compelling investment environments. Gujarat provides subsidised industrial land in Sanand, Daman, and Dahej SEZ, with capex subsidies of 8-12 percent for MSME-classified projects. Maharashtra's MIDC framework offers accelerated environmental clearances for pharmaceutical-adjacent projects in Chakan and Ranjangaon. Tamil Nadu's SIDCO infrastructure in Sriperumbudur serves the electronics manufacturing cluster, aligning with the fastest-growing cleanroom sub-segment.

What are the key certifications required for cleanroom HVAC suppliers targeting pharmaceutical clients?

Pharmaceutical cleanroom HVAC suppliers must hold BIS certification under IS 17511 (HVAC equipment) and demonstrate compliance with Schedule M (Revised) under the Drugs and Cosmetics Rules, 1945. ISO 14644 cleanroom classification certification from NABCB-accredited agencies is mandatory for project execution. Additionally, projects supplying to USFDA-approved pharmaceutical facilities require validation documentation meeting FDA 21 CFR Part 11 requirements for electronic records and signatures.

How do Chinese and European cleanroom HVAC suppliers compare on cost and performance?

European suppliers (Swegon, Systemair, Camfil) offer AHUs at ₹8,000-12,000 per CFM with energy-efficient EC-plug-fan technology and superior thermal performance. Chinese suppliers (Yovog, Shinco) price equivalent AHUs at ₹4,500-6,500 per CFM, representing 25-30 percent cost advantage. Indian manufacturers (Synergy Green, Greenheck India) occupy the mid-market at ₹6,000-8,000 per CFM. For the ₹15-25 crore CapEx band, a hybrid sourcing strategy combining European blowers and motors with Indian-manufactured sheet-metal components is recommended for pharmaceutical applications.

What financing options are available for MSME-classified cleanroom HVAC projects?

MSME Udyam-registered projects qualify for priority-sector lending from SBI, HDFC Bank, and Axis Bank at 8.75-9.50 percent for term loans up to ₹25 crore. SIDBI's Clean Technology Fund offers interest rebates of 0.50-1.25 percent for energy-efficient systems meeting BEE star ratings. CGTMSE guarantees cover up to 85 percent of credit exposure, improving loan-to-value ratios. State MSME schemes in Gujarat, Maharashtra, and Tamil Nadu provide additional capex subsidies of 8-12 percent for qualifying projects.

Not sure which tier you need?

Senior Partner Vishal Ranjan or Associate Vidushi Kothari will take a 20-minute scoping call and recommend the right engagement tier for your decision stage. Response within one business day.